Search - tctmd.com

Displaying 101 - 120 of 491

Sort: Relevancy | Date

Presentation TVT 2023

Patients With AS and Atrial Fibrillation: Updates on the WATCH-TAVR Trial

Presenter: Brian Whisenant

June 08, 2023

Presentation TVT 2023

Comparative Effectiveness of Left Atrial Appendage Closure and Direct Oral Anticoagulants in Atrial Fibrillation Patients: A Meta-Analysis

Presenter: Olayiwola Bolaji

June 08, 2023

Presentation TVT 2023

Colchicine for Prevention of Post PFO Closure Atrial Fibrillation

Presenter: Veronica Andre

June 08, 2023

Presentation EuroPCR 2023

Low Dose Direct Oral Anticoagulation vs. DAPT after LAAO - ADALA Trial

Presenter: Xavier Freixa

May 17, 2023

Presentation ACC 2023

Pulsed Field Ablation Treatment in Paroxysmal and Persistent Atrial Fibrillation Patients: Acute and Long-term Outcomes from the PULSED AF Pivotal Trial

Presenter: Atul Verma

March 05, 2023

Presentation Miami Valves 2023

A Revolutionary Approach to Left Atrial Appendage Closure

Presenter: Saibal Kar

February 04, 2023

Presentation Miami Valves 2023

Wearable Defibrillators

Presenter: Alex Velasquez

February 03, 2023

Presentation Miami Valves 2023

50 years of Sudden Cardiac Death Prevention: Progress, Promises, and Pitfalls

Presenter: Robert J. Myerburg

February 03, 2023

Presentation Miami Valves 2023

Implementation of the shock team

Presenter: Rohan Goswami

February 02, 2023

Presentation TCT 2022

TCT 103: Impact of pre-existing and new atrial fibrillation on major adverse cardiac events following coronary revascularization

Presenter: Omar Abdel-Razek

September 18, 2022

Presentation TCT 2022

TCT 381: Vitamin K Antagonists, Direct Oral Anticoagulants, or Left Atrial Appendage Closure for Patients with Nonvalvular Atrial Fibrillation: A Systematic Review and Network Meta-Analysis

Presenter: Davide Cao

September 18, 2022

Presentation TCT 2022

TCT 1: Bleeding in Patients with Atrial Fibrillation and Acute Coronary Syndrome or PCI treated with Antithrombotic Therapy: Insights from the AUGUSTUS Trial

Presenter: Dennis Narcisse

September 17, 2022

Presentation TCT 2022

TCT 20: Relative benefit of double versus triple antithrombotic therapy in patients with atrial fibrillation randomized earlier versus later after index coronary event: Insights from the AUGUSTUS Trial

Presenter: Alexander Fanaroff

September 17, 2022

Presentation ESC 2022

Smartphone-based screening for atrial fibrillation (eBRAVE-AF) – A pragmatic siteless digital randomized clinical trial

Presenter: Axel Bauer

August 28, 2022

Presentation TVT 2022

LAAO for Atrial Fibrillation After TAVR: The Other Elephant In The Room

Presenter: Amar Krishnaswamy

June 10, 2022

Presentation ARCH 2022

Use of Imaging in Calcified and Fibrotic Lesions

Presenter: Marc Sintek

April 23, 2022

Presentation THT 2022

The Effect of Rhythm vs. Rate Control for Atrial Fibrillation on Mortality and Hospitalization in Patients With Heart Failure With Preserved Ejection Fraction: Updated Meta-Analysis

Presenter: Mohammed Al-Sadawi

February 01, 2022

Presentation Controversies and Advances 2021

Device Detected Atrial Fibrillation: NOAC or Not?

Presenter: Roopinder K. Sandhu

December 03, 2021

Presentation Controversies and Advances 2021

In Defense of Digoxin

Presenter: John Mandrola

December 03, 2021

Presentation Controversies and Advances 2021

Role of Digoxin in Heart Failure and Atrial Fibrillation

Presenter: Michelle M. Kittleson

December 03, 2021

Advertisement

Patients With AS and Atrial Fibrillation: Updates on the WATCH-TAVR Trial

Comparative Effectiveness of Left Atrial Appendage Closure and Direct Oral Anticoagulants in Atrial Fibrillation Patients: A Meta-Analysis

Colchicine for Prevention of Post PFO Closure Atrial Fibrillation

Low Dose Direct Oral Anticoagulation vs. DAPT after LAAO - ADALA Trial

Pulsed Field Ablation Treatment in Paroxysmal and Persistent Atrial Fibrillation Patients: Acute and Long-term Outcomes from the PULSED AF Pivotal Trial

A Revolutionary Approach to Left Atrial Appendage Closure

Wearable Defibrillators

50 years of Sudden Cardiac Death Prevention: Progress, Promises, and Pitfalls

Implementation of the shock team

TCT 103: Impact of pre-existing and new atrial fibrillation on major adverse cardiac events following coronary revascularization

TCT 381: Vitamin K Antagonists, Direct Oral Anticoagulants, or Left Atrial Appendage Closure for Patients with Nonvalvular Atrial Fibrillation: A Systematic Review and Network Meta-Analysis

TCT 1: Bleeding in Patients with Atrial Fibrillation and Acute Coronary Syndrome or PCI treated with Antithrombotic Therapy: Insights from the AUGUSTUS Trial

TCT 20: Relative benefit of double versus triple antithrombotic therapy in patients with atrial fibrillation randomized earlier versus later after index coronary event: Insights from the AUGUSTUS Trial

Smartphone-based screening for atrial fibrillation (eBRAVE-AF) – A pragmatic siteless digital randomized clinical trial

LAAO for Atrial Fibrillation After TAVR: The Other Elephant In The Room

Use of Imaging in Calcified and Fibrotic Lesions

The Effect of Rhythm vs. Rate Control for Atrial Fibrillation on Mortality and Hospitalization in Patients With Heart Failure With Preserved Ejection Fraction: Updated Meta-Analysis

Device Detected Atrial Fibrillation: NOAC or Not?

In Defense of Digoxin

Role of Digoxin in Heart Failure and Atrial Fibrillation

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content